欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2003, Vol. 8 ›› Issue (4): 434-437.

• 研究原著 • 上一篇    下一篇

加替沙星片与左氧氟沙星片治疗轻中度急性下呼吸道感染的临床疗效比较

王莹   

  1. 皖南医学院弋矶山医院呼吸内科,芜湖 241001,安徽
  • 收稿日期:2003-03-03 修回日期:2003-04-05 出版日期:2003-08-26 发布日期:2020-11-19
  • 通讯作者: 王莹,女,副教授,副主任医师,主要从事临床呼吸系统疾病的研究。Tel:0553-5723766

Comparison of efficacy and safety between gatifloxacin andlevofloxacin in treatment ofPatients withlight to moderate acutelower respiratory tract infections

WANG Ying   

  1. Department of Respiration,Yijishan Hospital,Wannan Medical College,Wuhu 241001,Anhui,China
  • Received:2003-03-03 Revised:2003-04-05 Online:2003-08-26 Published:2020-11-19

摘要: 目的 比较加替沙星片与左氧氟沙星片治疗轻、中度急性下呼吸道感染的有效性和安全性。方法 经临床确诊的轻、中度急性下呼吸道感染患者39 例,其中加替沙星组20 例,口服加替沙星片0.2 g,2 次/d ;左氧氟沙星组19 例,口服左氧氟沙星片0.2 g,2 次/d,疗程均为5 ~ 10 d 。结果 加替沙星组和左氧氟沙星组痊愈率分别为75 %(14/20)和73.7 %(14/19),有效率分别为95 %和94.7 %(P>0.05),两组细菌清除率分别为100 %和90 %(P>0.05)。两组间临床和细菌学疗效差异无显著性。两组不良事件发生率分别为10.0 %和10.5 %,主要为消化道反应。加替沙星组有4 例(20.0 %)、左氧氟沙星组有5 例(26.3 %)出现谷丙转氨酶的轻度升高,但不影响治疗。结论 加替沙星片能安全有效地治疗轻、中度急性下呼吸道感染。

关键词: 药效学, 加替沙星, 左氧氟沙星, 随机对照研究, 急性下呼吸道感染

Abstract: AIM: To compare efficacy and safety of gatifloxacin andlevofloxacin by a randomized controlled trial in treatment ofPatients withlight to moderate acutelower respiratory tract infections.METHODS: 39 cases were assigned to two groups:20 in gatifloxacin grouPand 19 inlevofloxacin group.The dose of gatifloxacin was 0.2 gPer tablet,po,two times a day and the same tolevofloxacin.The course of treatment was 5 -10 d.RESULTS: The clinical curative rates of gatifloxacin andlevofloxacin groups were 75 %(14/20)and 63.16 %(12/19),the effective rates were 100 % and 90 %(P>0.05),bacterial clearance were 100 % and 90 %,and adverse reaction rates were 10 %(2/20)and 10.53 %(2/19),respectively.All those adverse reactions were mainly gastrointestinal tract reactions.The abnormality oflaboratory inspections associated with trial drugs happened to 4 and 5Patients in two groups.The reactions were mostlylight increase of aminotransferase without effect on therapy.CONCLUSION: Gatifloxacin is an antibiotic withlarge antimicrobial spectrum and can be recommended to treatlight to moderate acutelower respiratory tract infections.

Key words: pharmacodynamics, gatifloxacin, levofloxacin, randomized controlled trial, acutelower respiratory tract infections

中图分类号: